142 related articles for article (PubMed ID: 21452541)
1. [Assessment and reversibility of liver fibrosis in viral hepatitis].
Vallet-Pichard A; Pol S; Mallet V
Rev Prat; 2011 Jan; 61(1):39-43. PubMed ID: 21452541
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies.
Poynard T; Ngo Y; Munteanu M; Thabut D; Massard J; Moussalli J; Varaud A; Benhamou Y; Ratziu V
Antivir Ther; 2010; 15(4):617-31. PubMed ID: 20587855
[TBL] [Abstract][Full Text] [Related]
3. [Reversibility of hepatitis B virus-induced liver cirrhosis after prolonged antiviral therapy].
Pérez Roldán F; Vives Domínguez L; González Carro P; Villafáñez García MC; Fernández Acenero MJ; Cuesta Domínguez R; Aoufi Rabih S; Ruíz Carrillo F
Gastroenterol Hepatol; 2010; 33(7):498-503. PubMed ID: 20630622
[TBL] [Abstract][Full Text] [Related]
4. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.
Castera L
J Viral Hepat; 2009 May; 16(5):300-14. PubMed ID: 19254351
[TBL] [Abstract][Full Text] [Related]
5. Advances in the treatment of hepatitis C.
Lawrence SP
Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B: liver fibrosis and hepatocellular carcinoma.
Lok AS
Gastroenterol Clin Biol; 2009; 33(10-11):911-5. PubMed ID: 19577871
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of fibrosis and cirrhosis. Liver biopsy is not always necessary.
Prescrire Int; 2010 Feb; 19(105):38-42. PubMed ID: 20455345
[TBL] [Abstract][Full Text] [Related]
9. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].
Gentilini P; Laffi G; La Villa G; Casini-Raggi V; Romanelli RG; Buzzelli G; Mazzanti R; Marra F; Pinzani M; Zignego AL
Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817
[TBL] [Abstract][Full Text] [Related]
10. [Interferon-alpha and liver fibrosis in patients with chronic damage due to hepatitis C virus].
Gonzalez-Huezo MS; Gallegos-Orozco JF
Rev Gastroenterol Mex; 2003; 68(3):239-44. PubMed ID: 14702938
[TBL] [Abstract][Full Text] [Related]
11. [Reversibility of advanced liver fibrosis--therapeutic possibility and biochemical monitoring of the disease].
Lebensztejn DM
Przegl Epidemiol; 2005; 59(2):535-40. PubMed ID: 16190564
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis G infection and therapeutic response to interferon in HCV-related chronic liver disease.
Pramoolsinsap C; Poovorawan Y; Sura T; Theamboonlers A; Busagorn N; Kurathong S
Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):480-90. PubMed ID: 10437943
[TBL] [Abstract][Full Text] [Related]
13. Projecting future complications of chronic hepatitis C in the United States.
Davis GL; Albright JE; Cook SF; Rosenberg DM
Liver Transpl; 2003 Apr; 9(4):331-8. PubMed ID: 12682882
[TBL] [Abstract][Full Text] [Related]
14. A patient with chronic hepatitis B and regression of fibrosis during treatment.
Chang CY; Martin P; Fotiadu A; Hytiroglou P
Semin Liver Dis; 2010 Aug; 30(3):296-301. PubMed ID: 20665381
[TBL] [Abstract][Full Text] [Related]
15. Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response.
Rao HY; Wei L; Li J; Zhang LF; Chen HY; Zhu LM; Liu F; Sun Y; Wang H
Hepatogastroenterology; 2009; 56(90):328-34. PubMed ID: 19579592
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and histologic surveillance of hepatitis C].
Bralet MP; Zafrani ES
Rev Prat; 2000 May; 50(10):1078-82. PubMed ID: 10905092
[TBL] [Abstract][Full Text] [Related]
17. Fibroscan and FibroTest/FibroMax to assess liver fibrosis/cirrhosis in patients with chronic HBV and HCV infection in Georgia.
Dolmazashvili E; Zhamutashvili M; Svanidze M; Nizharadze N; Abutidze A
Georgian Med News; 2008 Dec; (165):83-7. PubMed ID: 19124923
[TBL] [Abstract][Full Text] [Related]
18. [The methods of estimation and monitoring liver fibrosis in patients with chronic viral hepatitis].
Lebensztejn DM
Pol Merkur Lekarski; 2001 Dec; 11(66):522-5. PubMed ID: 11899853
[TBL] [Abstract][Full Text] [Related]
19. Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis.
Arrieta O; Rodriguez-Diaz JL; Rosas-Camargo V; Morales-Espinosa D; Ponce de Leon S; Kershenobich D; Leon-Rodriguez E
Cancer; 2006 Oct; 107(8):1852-8. PubMed ID: 16967451
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease.
Naveau S; Gaudé G; Asnacios A; Agostini H; Abella A; Barri-Ova N; Dauvois B; Prévot S; Ngo Y; Munteanu M; Balian A; Njiké-Nakseu M; Perlemuter G; Poynard T
Hepatology; 2009 Jan; 49(1):97-105. PubMed ID: 19053048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
